Research graph
References from A Composite Ovine Forestomach Matrix and Hyaluronic Acid CAMP for the Treatment of Full Thickness Wounds of the Foot in People With Diabetes: A Randomized Controlled Trial. Local targets link to admitted publications; unresolved targets remain external evidence.
Diabetic Foot Ulcers: A Review
10.1001/jama.2023.10578 · 2023 · External reference
7 Regions Foot Ulcer Costs Study Group. Estimated Costs of Treating Two Standardised Diabetes‐Related Foot Ulcers of Different Severity ‐ A Comparison of 7 Global Regions
10.1016/j.diabres.2025.112036 · 2025 · External reference
Diabetic Foot Ulcers and Their Recurrence
10.1056/nejmra1615439 · 2017 · External reference
Emerging Technologies for the Management of Diabetic Foot Ulceration: A Review
10.3389/fcdhc.2024.1440209 · 2024 · External reference
Microenvironment of Diabetic Foot Ulcers: Implications for Healing and Therapeutic Strategies
10.4103/jrms.jrms_573_24 · 2025 · External reference
Five Year Mortality and Direct Costs of Care for People With Diabetic Foot Complications Are Comparable to Cancer
10.1186/s13047-020-00383-2 · 2020 · External reference
10.3402/dfa.v4i0.21847
10.3402/dfa.v4i0.21847 · External reference
Higher Rates of All‐Cause Mortality and Resource Utilization During Episodes‐Of‐Care for Diabetic Foot Ulceration
10.1016/j.diabres.2021.109182 · 2022 · External reference
Etiology, Epidemiology, and Disparities in the Burden of Diabetic Foot Ulcers
10.2337/dci22-0043 · 2023 · External reference
Diabetic Foot Ulcers: Appraising Standard of Care and Reviewing New Trends in Management
10.1007/s40257-019-00495-x · 2020 · External reference
Skin Substitutes as Treatment for Chronic Wounds: Current and Future Directions
10.3389/fmed.2023.1154567 · 2023 · External reference
Best Practice for Wound Repair and Regeneration Use of Cellular, Acellular and Matrix‐Like Products (CAMPs)
10.12968/jowc.2023.32.sup4b.s1 · 2023 · External reference
Cellular, Acellular, and Matrix‐Like Products (CAMPs) for Soft‐Tissue Reconstruction in Acute Surgical and Traumatic Wounds
10.12968/jowc.2025.34.sup3a.s1 · 2025 · External reference
The Hidden Costs of Limiting Access: Clinical and Economic Risks of Medicare's Future Effective Cellular, Acellular and Matrix‐Like Products (CAMPs) Local Coverage Determination
10.12968/jowc.2025.0120 · 2025 · External reference
Observed Impact of Skin Substitutes in Lower Extremity Diabetic Ulcers: Lessons From the Medicare Database (2015‐2018)
10.12968/jowc.2021.30.sup7.s5 · 2021 · External reference
Meta‐Analysis of Cellular and Acellular Tissue‐Based Products Demonstrates Improvement of Diabetic Foot Ulcer Healing Despite Age and Wound Size
10.1016/j.jvsvi.2025.100215 · 2025 · External reference
A Functional Extracellular Matrix Biomaterial Derived From Ovine Forestomach
10.1016/j.biomaterials.2010.02.025 · 2010 · External reference
Ovine Forestomach Matrix Biomaterial Is a Broad Spectrum Inhibitor of Matrix Metalloproteinases and Neutrophil Elastase
10.1111/j.1742-481x.2012.01106.x · 2014 · External reference
Quantification of In Vitro and In Vivo Angiogenesis Stimulated by Ovine Forestomach Matrix Biomaterial
10.1016/j.biomaterials.2011.05.040 · 2011 · External reference
A Novel Chemotactic Factor Derived From the Extracellular Matrix Protein Decorin Recruits Mesenchymal Stromal Cells In Vitro and In Vivo
10.1371/journal.pone.0235784 · 2020 · External reference
Clinical Outcomes Following the Use of Ovine Forestomach Matrix (Endoform Dermal Template) to Treat Chronic Wounds
10.1097/01.asw.0000428862.34294.d4 · 2013 · External reference
Use of Ovine‐Based Collagen Extracellular Matrix and Gentian Violet/Methylene Blue Antibacterial Foam Dressings to Help Improve Clinical Outcomes in Lower Extremity Wounds: A Retrospective Cohort Study
2017 · External reference
Use of an Ovine Collagen Dressing With Intact Extracellular Matrix to Improve Wound Closure Times and Reduce Expenditures in a US Military Veteran Hospital Outpatient Wound Center
2017 · External reference
Comparative Effectiveness of Two Collagen‐Containing Dressings: Oxidized Regenerated Cellulose (ORC)/Collagen/Silver‐ORC Dressing Versus Ovine Collagen Extracellular Matrix
2019 · External reference
Prospective Multicenter Evaluation of an Advanced Extracellular Matrix for Wound Management
10.1097/01.asw.0000667052.74087.d6 · 2020 · External reference
Retrospective Real‐World Comparative Effectiveness of Ovine Forestomach Matrix and Collagen/ORC in the Treatment of Diabetic Foot Ulcers
10.1111/iwj.13670 · 2022 · External reference
Use of an Advanced Extracellular Matrix Dressing in the Treatment of Acute and Chronic Wounds: A Malaysian Case Series
2022 · External reference
Limb Salvage via Surgical Soft‐Tissue Reconstruction With Ovine Forestomach Matrix Grafts: A Prospective Study
10.1097/gox.0000000000006406 · 2024 · External reference
Ovine Forestomach Matrix in the Surgical Management of Complex Lower‐Extremity Soft‐Tissue Defects: A Retrospective Multi‐Center Case Series
10.7547/22-081 · 2023 · External reference
Further Structural Characterization of Ovine Forestomach Matrix and Multi‐Layered Extracellular Matrix Composites for Soft Tissue Repair
10.1177/08853282211045770 · 2022 · External reference
Effectiveness of Hyaluronic Acid and Its Derivatives on Diabetic Foot Ulcer: A Systematic Review and Meta‐Analysis
10.3389/fendo.2025.1627558 · 2025 · External reference
Development of Hyaluronic Acid‐Based Hydrogels for Chronic Diabetic Wound Healing: A Review
10.1016/j.ijbiomac.2025.142273 · 2025 · External reference
Therapeutic Potential of Hyaluronic Acid in Diabetic Foot Ulcer Healing: A Systematic Review and Bibliometric Analysis
2025 · External reference
A Composite Dermal Matrix Comprising Ovine Forestomach Matrix and Hyaluronic Acid in the Treatment of Chronic Wounds Secondary to Calciphylaxis: A Case Series and Literature Review
10.1097/asw.0000000000000361 · 2025 · External reference
Innovative Treatment of Diabetic Ulcers: Combining Chemical Debridement and Xenograft Applications: A Case Study
10.12968/jowc.2025.0010 · 2025 · External reference
Early Experience With a Composite Ovine Forestomach Matrix Graft in Chronic Lower Extremity Wounds: A Multi‐Center Retrospective Case Series
10.1093/jscr/rjag129 · 2026 · External reference
Multi‐Centre Prospective Randomised Controlled Clinical Trial to Evaluate a Bioactive Split Thickness Skin Allograft vs Standard of Care in the Treatment of Diabetic Foot Ulcers
10.1111/iwj.13759 · 2022 · External reference
A Multi‐Centre, Single‐Blinded Randomised Controlled Clinical Trial Evaluating the Effect of Resorbable Glass Fibre Matrix in the Treatment of Diabetic Foot Ulcers
10.1111/iwj.13675 · 2021 · External reference
Use of a Purified Reconstituted Bilayer Matrix in the Management of Chronic Diabetic Foot Ulcers Improves Patient Outcomes vs Standard of Care: Results of a Prospective Randomised Controlled Multi‐Centre Clinical Trial
10.1111/iwj.13715 · 2022 · External reference
A Borate‐Based Bioactive Glass Advances Wound Healing in Non‐Healing Wagner Grade 1 Diabetic Foot Ulcers: A Randomised Controlled Clinical Trial
10.1111/iwj.70763 · 2025 · External reference
Assessing the Quality of Life of People With Chronic Wounds by Using the Cross‐Culturally Valid and Revised Wound‐QoL Questionnaire
10.1111/wrr.12901 · 2021 · External reference
A Multicentre Clinical Trial Evaluating the Outcomes of Two Application Regimens of a Unique Keratin‐Based Graft in the Treatment of Wagner Grade One Non‐Healing Diabetic Foot Ulcers
10.1111/iwj.70029 · 2024 · External reference
Comparing the Efficacy of a Unique Advanced Bioengineered Type‐I Collagen‐Based Skin Substitute Versus an Amnion Graft With Standard of Care in the Treatment of Non‐Healing Diabetic Foot Ulcers: A Randomized Clinical Trial
2025 · External reference
Adaptive Increase in Sample Size When Interim Results Are Promising: A Practical Guide With Examples
10.1002/sim.4102 · 2011 · External reference
Causes, Prevention, and Management of Diabetes‐Related Foot Ulcers
10.1016/s2213-8587(24)00110-4 · 2024 · External reference
To Cross‐Link or Not to Cross‐Link? Cross‐Linking Associated Foreign Body Response of Collagen‐Based Devices
10.1089/ten.teb.2014.0290 · 2015 · External reference
Immune Response to Biologic Scaffold Materials
10.1016/j.smim.2007.11.003 · 2008 · External reference
Functional Insights From the Proteomic Inventory of Ovine Forestomach Matrix
10.1021/acs.jproteome.8b00908 · 2019 · External reference
Hyaluronic Acid and Skin: Its Role in Aging and Wound‐Healing Processes
10.3390/gels11040281 · 2025 · External reference
Hyaluronic Acid in Inflammation and Tissue Regeneration
2016 · External reference
Size Matters: Molecular Weight Specificity of Hyaluronan Effects in Cell Biology. Int
2015 · External reference
Hyaluronan as an Immune Regulator in Human Diseases
10.1152/physrev.00052.2009 · 2011 · External reference
Hyaluronan Fragments: An Information‐Rich System
10.1016/j.ejcb.2006.05.009 · 2006 · External reference
Tissue Integrity Signals Communicated by High‐Molecular Weight Hyaluronan and the Resolution of Inflammation
10.1007/s12026-014-8495-2 · 2014 · External reference
High Molecular Weight Hyaluronic Acid Inhibits IL‐6‐Induced MMP Production From Human Chondrocytes by Up‐Regulating the ERK Inhibitor, MKP‐1
10.1016/j.bbrc.2010.10.135 · 2010 · External reference
10.1007/978-3-031-30300-5_9
10.1007/978-3-031-30300-5_9 · 2023 · External reference
Chemical Modifications of Hyaluronic Acid for the Synthesis of Derivatives for a Broad Range of Biomedical Applications
10.1016/j.carbpol.2011.03.019 · 2011 · External reference
Hyaluronic Acid Dressing (Healoderm) in the Treatment of Diabetic Foot Ulcer: A Prospective, Randomized, Placebo‐Controlled, Single‐Center Study
10.1111/wrr.12428 · 2016 · External reference
Two‐Step Autologous Grafting Using HYAFF Scaffolds in Treating Difficult Diabetic Foot Ulcers: Results of a Multicenter, Randomized Controlled Clinical Trial With Long‐Term Follow‐Up
10.1177/1534734611409371 · 2011 · External reference
HYAFF 11‐Based Autologous Dermal and Epidermal Grafts in the Treatment of Noninfected Diabetic Plantar and Dorsal Foot Ulcers: A Prospective, Multicenter, Controlled, Randomized Clinical Trial
10.2337/diacare.26.10.2853 · 2003 · External reference
Effectiveness and Safety of a Novel Gel Dressing in the Management of Neuropathic Leg Ulcers in Diabetic Patients: A Prospective Double‐Blind Randomized Trial
10.1177/1534734609344140 · 2009 · External reference
10.1089/152091504773731357
10.1089/152091504773731357 · External reference
10.1111/dme.12509
10.1111/dme.12509 · External reference
10.1016/j.jvs.2013.08.003
10.1016/j.jvs.2013.08.003 · External reference
Unresolved reference
External reference
Unresolved reference
External reference
